Featured Research

from universities, journals, and other organizations

Influenza Nasal Spray Vaccine Produces Local Antibody Response

Date:
May 3, 1998
Source:
Vanderbilt University Medical Center
Summary:
A recent study presented at the 1998 Society for Pediatrc Research Annual Meeting shows that a nasal spray is more effective then shots for vaccinating against influenza.

A new nasal spray vaccine is being studied that may prove to be an effective way of vaccinating children against influenza. A recent study presented at the 1998 Society for Pediatric Research Annual Meeting shows that children given the new vaccine developed anti-influenza antibodies in their nasal secretions.

Influenza epidemics occur yearly and are an important cause of wintertime respiratory illness throughout the world. Infection rates are highest in young children, often exceeding 40%. A current vaccine is given by intramuscular injection and is not routinely administered to healthy children.

Vaccines work by stimulating the body's immune system to make antibodies against the infectious agent. It is unknown what types of antibodies are most important in protecting against influenza.

"Traditionally, antibodies measured in the blood are used as a marker for protection. However, there is some evidence that antibodies in the nose, where the virus first enters the body, are more important for protection," said Dr. Thomas Boyce, fellow in Pediatric Infectious Diseases at Vanderbilt University Medical Center.

Knowing which types of antibodies the intranasal influenza vaccine stimulates will be important in refining future versions of the vaccine.

"In our study we sought to determine whether the intranasal influenza vaccine causes the production of local antibodies in the nose (mucosal IgA antibodies)," said Boyce.

Researchers at Vanderbilt obtained nasal washes on 19 children before and after they had been given either the intranasal influenza vaccine or a placebo. They then tested the nasal washes for mucosal IgA antibodies to the three different influenza strains contained in the vaccine. The majority of children who had been given the vaccine developed mucosal IgA antibodies to all three influenza strains, whereas most of the children who received placebo did not.

"The nasal spray vaccine appears to stimulate the production of local antibodies in the nose, where influenza enters the body," said Boyce. "We hope these antibodies will stop the virus in its tracks, before it has a chance to spread to the rest of the respiratory system."

Further studies are under way to determine if the presence of these local antibodies correlates with protection from infection with the influenza virus.


Story Source:

The above story is based on materials provided by Vanderbilt University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Vanderbilt University Medical Center. "Influenza Nasal Spray Vaccine Produces Local Antibody Response." ScienceDaily. ScienceDaily, 3 May 1998. <www.sciencedaily.com/releases/1998/04/980423101431.htm>.
Vanderbilt University Medical Center. (1998, May 3). Influenza Nasal Spray Vaccine Produces Local Antibody Response. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/1998/04/980423101431.htm
Vanderbilt University Medical Center. "Influenza Nasal Spray Vaccine Produces Local Antibody Response." ScienceDaily. www.sciencedaily.com/releases/1998/04/980423101431.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins